Efficacy and Safety of Stapokibart for Primary Cutaneous Amyloidosis
NCT07143864
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Primary Cutaneous Amyloidosis
Interventions
BIOLOGICAL:
Stapokibart
OTHER:
Placebo drug
Sponsor
First Affiliated Hospital of Chongqing Medical University